Chargement en cours...
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
Cannabinoid receptor 2 agonists and inverse agonists are emerging as new therapeutic options for a spectrum of autoimmune-related disease. Of particular interest, is the ability of CB2 ligands to regulate microglia function in neurodegenerative diseases and traumatic brain injury. We have previously...
Enregistré dans:
| Publié dans: | Pharmacol Res Perspect |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4506688/ https://ncbi.nlm.nih.gov/pubmed/26196013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.159 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|